WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Cough, Cold and Allergy (Hay Fever) Remedies in the US

Euromonitor International, April 2012, Pages: 54

In 2011, Chattem Inc’s Allegra brand of antihistamine/allergy remedies (systemic) switched from Rx-to-OTC, representing one of the largest switches in the segment’s history. First stocked on store shelves in March, Chattem accompanied Allegra’s launch with significant promotional spending both in-store and via media outlets. Attractive end-caps and displays at major retailers heralded the brand’s switch, while television and online advertisements appeared with great frequency. With its switch...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US
Euromonitor International
April 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 3 Sales of Decongestants by Category: Value 2006-2011
Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011
Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
Bayer Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 Bayer Corp: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Bayer Corp: Competitive Position 2011
Chattem Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 3 Chattem Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Chattem Inc: Competitive Position 2011
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 5 CVS Caremark Corp: Key Facts
Summary 6 CVS Caremark Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 CVS Caremark Corp: Competitive Position 2011
GlaxoSmithKline Consumer Health in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 8 GlaxoSmithKline Consumer Health: Key Facts
Company Background
Production
Competitive Positioning
Summary 9 GlaxoSmithKline Consumer Health: Competitive Position 2011
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 10 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Summary 11 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2011
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 13 Pfizer Consumer Healthcare Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 14 Pfizer Consumer Healthcare Inc: Competitive Position 2011
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 15 Walgreen Co: Key Facts
Summary 16 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 17 Walgreen Co: Competitive Position 2011
Executive Summary
Consumer Health Sales Hit All-time High
Vitamins and Dietary Supplements Performs the Best
No End in Sight for Recalls
Distribution Continues To Consolidate
Growth Expected To Slow As Categories Mature, Sluggish Economy Persists
Key Trends and Developments
Persistent Recalls Define Another Year in OTC
Acquisitions Shake Up OTC Competitive Landscape
Increasing Media Attention Drives Supplementation Fever
Growing Mainstream Appeal Catapults Sports Nutrition Sales
Tonics and Bottled Nutritive Drinks: the New Mega-category
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 12 Life Expectancy at Birth 2006-2011
Market Data
Table 13 Sales of Consumer Health by Category: Value 2006-2011
Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 15 Consumer Health Company Shares 2007-2011
Table 16 Consumer Health Brand Shares 2008-2011
Table 17 Penetration of Private Label by Category 2006-2011
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 18 OTC - Switches 2009-2011
Sources
Summary 19 Research Sources

Customers who bought this item also bought